A review of life science current events reported by MedCity News this week:
Cleveland Clinic hotel on main campus undergoes ‘wellness’ renovation. The InterContinental Suites Hotel’s nine-month-long renovation project is scheduled to wrap up this week and will create what appears to be Ohio’s only wellness hotel associated with a hospital.
Barely a peep (tweet) out of Medtronic CEO Omar Ishrak. In 30 days, Ishrak has had exactly three — yes, that’s right, three — tweets.
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Cleveland Clinic, Chris Coburn’s big payoff (and challenge): $840,000. Obviously the Clinic wants to reward star performers like Coburn for the financial gain they’ve helped bring to the health system. But it’s not a stretch to think that it could easily cause tension within such a physician-centric organization: a non-physician is suddenly out-earning all but the Clinic’s brightest of rockstar doctors.
GSK’s lupus drug Benlysta gets Health Canada approval. Lupus drug Benlysta, developed by GlaxoSmithKline (NYSE:GSK) and drug partner Human Genome Sciences (NASDAQ:HGSI), can now count Canada among the markets where it will offer the first new lupus treatment in nearly 50 years.
Medical device dry-eye treatment LipiFlow wins FDA approval. North Carolina’s TearScience has won FDA approval for its LipiFlow Thermal Pulsation device, which can eliminate gland blockages that in many cases keep the eye from being properly lubricated.